Abstract:BACKGROUND: To date, the use of bone marrow-derived mesenchymal stem cells (MSCs) for the treatment of Parkinson's disease have solely focused on in vivo animal models. Because of the number of influencing factors, it has been difficult to determine a consistent outcome.OBJECTIVE: To establish an injury model in brain slices of substantia nigra and striaturn using 1-methyl-4-phonylpytidinium ion (MPP), and to investigate the effect of MSCs on dopaminergic neurons following MPP+ induced damage.DESIGN, TIME AND SETTING: An in vitro, randomized, controlled, animal experiment using immunohistochemistry was performed at the Laboratory of the Department of Anatomy, Fudan University between January 2004 and December 2006.MATERIALS: Primary MSC cultures were obtained from femurs and tibias of adult Sprague Dawley rats. Organotypic brain slices were isolated from substantia nigra and striaturn of 1-day-old Sprague Dawley rat pups. Monoclonal antibodies for tyrosine hydroxylase (TH, 1:5 000) were from Santa Cruz (USA); goat anti-rabbit IgG antibodies labeled with FITC were from Boster Company (China).METHODS: Organotypic brain slices were cultured for 5 days in whole culture medium supplemented with 50% DMEM, 25% equine serum, and 25% Tyrode's balanced salt solution. The medium was supplemented with 5 mu g/mLAra-C, and the culture was continued for an additional 5 days. The undergrowth of brain slices was discarded at day 10. Eugonic brain slices were cultured with basal media for an additional 7 days. The brain slices were divided into three groups: control, MPP+ exposure, and co-culture. For the MPP+ group, MPP+ (30 mu mol/L) was added to the media at day 17 and brain slices were cultured for 4 days, followed by control media. For the co-culture group, the MPP+ injured brain slices were placed over MSCs in the well and were further cultured for 7 days. MAINOUTCOME MEASURES: After 28 days in culture, neurite outgrowth was examined in the brain slices under phase-contrast microscopy. The percent of area containing dead cells in each brain slice was calculated with the help of propidium iodide fluorescence. Brain slices were stained with antibodies for TH to indicate the presence of dopaminergic neurons. Transmission electron microscopy was applied to determine the effect of MSCs on neuronal ultrastructure.RESULTS: Massive cell death and neurite breakage was observed in the MPP+ group. In addition, TH expression was significantly reduced, compared to the control group (P < 0.01). After 7 days in culture With MSCs, the co-culture group presented with less cell damage and reduced neurite breakage, and TH expression was increased. However, these changes were not significantly different from the MPP+ group (P < 0.01). Electron microscopy revealed reduced ultrastructural injury to cells in the brain slices. However, vacuoles were present in cells, With some autophagic vacuoles.CONCLUSION: Bone marrow-derived MSCs can promote survival of dopaminergic neurons following MPP+-induced neurotoxicity in co-cultures with substantia nigra and striaturn brain slices.

INFLUENCES ON THE MONOAMINE NEUROTRANSMITTERS BY CO-CULTURING BONE MARROW STROMAL CELLS ONTO BRAIN SLICE OF PARKINSON’ RAT

Protective Effect of Bone Marrow-Derived Mesenchymal Stem Cells on Dopaminergic Neurons Against 1-Methyl-4-phenylpyridinium Ion-Induced Neurotoxicity in Rat Brain Slices

The effect of lentivirus-mediated PSPN genetic engineering bone marrow mesenchymal stem cells on Parkinson's disease rat model

The Effect of Lentivirus-Mediated PSPN Genetic Engineering Bone Marrow Mesenchymal Stem Cells on Parkinson’s Disease Rat Model

Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy

Establishment of cell models of dopaminergic neurons for Parkinson's disease

[Study on the levels of DA and metabolite in striatum in rats with Parkinson's disease treated by BDNF gene modified bone mesenchymal stem cells]

Study of SPIO Labeled or BrdU Labeled Bone Marrow Mesenchymal Stem Cells in Parkinson's Rat Model Following Transplantation

Study on bone marrow stromal cells induced in vitro to treat rat models of Parkinson's disease

Influences on expression of tyrosine hydroxylase in rats with Parkinson's disease treated by bone mesenchymal stem cell

Effect of Deep Brain Stimulation on Substantia Nigra Neurons in A Rat Model of Parkinson'S Disease

[Neurotoxicity effect of MPP+ on primary cultured mesencephalon neurons of SAMP8 mouse].

Neurobiological Characteristics of Human Histo-amniotic Mesenchymal and Its Effect to Treat Parkinson's Disease Modle Mice

Proton Magnetic Resonance Spectroscopic Changes in the Striatum in Rat Model of Parkinson's Disease

Mechanisms Restoring Cerebral Function of Bone Marrow Multipotent Adult Progenitor Cells after Transplantation in Parkinson' S Disease Rat Models

Neurotoxicity of cerebro-spinal fluid from patients with Parkinson's disease on mesencephalic primary cultures as an in vitro model of dopaminergic neurons

NEUROPROTECTIVE EFFECTS AND MECHANISM OF CITICOLINE ON PRIMARY CULTURED DOPAMINERGIC NEURONS OF MESENCEPHALON

Intracerebral transplantation of rat bone mesenchymal stem cells in a 6-hydroxydopamine rat model of Parkinson's disease

Migration and Differentiation of Mesenchymal Stem Cells Labeled with Enhanced Green Fluorescent Protein in the Parkinson's Disease Rat Brain

Effect of Coimplantation of Embryonic Olfactory Ensheathing Cells and Ventral Mesencephalic Cells on the Survival and Differentiation of Striatum Neurons in Parkinson's Disease Rats

Protective Effects of Valproic Acid on Dopaminergic Neurons of Rats in Vitro